MENU
+Compare
EOLS
Stock ticker: NASDAQ
AS OF
Jun 13 closing price
Price
$9.93
Change
-$0.25 (-2.46%)
Capitalization
846.82M

EOLS Evolus Forecast, Technical & Fundamental Analysis

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market... Show more

EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EOLS with price predictions
Jun 13, 2025

EOLS in -3.03% downward trend, declining for three consecutive days on June 13, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where EOLS declined for three days, in of 316 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where EOLS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EOLS entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 10, 2025. You may want to consider a long position or call options on EOLS as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EOLS just turned positive on June 02, 2025. Looking at past instances where EOLS's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EOLS advanced for three days, in of 297 cases, the price rose further within the following month. The odds of a continued upward trend are .

EOLS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EOLS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (80.645) is normal, around the industry mean (62.115). P/E Ratio (0.000) is within average values for comparable stocks, (88.968). EOLS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (3.879) is also within normal values, averaging (19.096).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EOLS is expected to report earnings to fall 67.63% to -9 cents per share on July 30

Evolus EOLS Stock Earnings Reports
Q2'25
Est.
$-0.10
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.13
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.13
The last earnings report on May 07 showed earnings per share of -30 cents, missing the estimate of -9 cents. With 1.19M shares outstanding, the current market capitalization sits at 846.82M.
A.I. Advisor
published General Information

General Information

a manufacturer of neurotoxins

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
520 Newport Center Drive
Phone
+1 949 284-4555
Employees
273
Web
https://www.evolus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPMX5.010.03
+0.60%
Invesco SteelPath MLP Alpha Plus C
GQGRX17.02-0.18
-1.05%
GQG Partners Emerging Markets Equity R6
RMOYX24.63-0.30
-1.20%
Victory RS Mid Cap Growth Y
APHGX25.40-0.35
-1.36%
Artisan Global Value Institutional
AWPYX21.74-0.36
-1.63%
AB Sustainable Intl Thematic Advisor

EOLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with AGBIF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then AGBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
-2.46%
AGBIF - EOLS
38%
Loosely correlated
N/A
AMRX - EOLS
35%
Loosely correlated
-2.64%
AQST - EOLS
32%
Poorly correlated
+3.32%
ALKS - EOLS
31%
Poorly correlated
-3.09%
NBIX - EOLS
29%
Poorly correlated
-0.50%
More